https://www.scrippsnews.com/health/medicine/fda-warns-certain-therapy-to-treat-cancer-may-cause-secondary-cancer
CAR-T therapies are approved under several products: Abecma, Breyanzi, Carvykti, Kymriah, Tecartus and Yescarta.
treat cancerfdawarnscertaintherapy
https://www.sciencedaily.com/releases/2024/09/240911112123.htm
The frequency of second primary malignancies (SPMs) arising in cancer survivors following treatment with CAR T-cell therapy was statistically comparable to the...
secondary cancersriskcartherapymay
https://www.aacr.org/blog/2024/09/16/new-perspectives-on-the-risk-of-secondary-cancers-after-car-t-cell-therapy/
Amidst an FDA investigation into secondary cancers after CAR T therapy, researchers show that the risk is likely minimal.
secondary cancerscell therapyriskcar